
Sciensus
Specialty pharmacy and healthcare services for complex conditions.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
Total Funding | 000k |
GBP | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 14 % | 10 % | 5 % | (26 %) | - | (21 %) | 9 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | 1 % | 1 % | 1 % | 1 % | 1 % | 1 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | - | 1 % | 1 % | 1 % | 1 % | 1 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
In 1992, pharmacists Rick and Lisa Vincent founded a company in the UK with a straightforward mission: to provide clinical care to patients in the comfort of their own homes. Initially known as Healthcare at Home, the business focused on a model that was gaining traction—moving complex medical care, traditionally delivered in hospitals, into a more convenient and patient-friendly setting. The company established itself as a key player in the clinical homecare market. Its model involved not just delivering medicines, but also providing the necessary nursing support and expertise to manage long-term and complex conditions. This integrated approach of pharmacy, logistics, and clinical services became its core strength. A pivotal moment in the company's journey arrived in 2012 when the private equity firm Vitruvian Partners acquired a majority stake in Healthcare at Home. This event provided the capital and strategic support needed for the next phase of growth, allowing the company to expand its services and reach. Under new ownership, the business continued to evolve its specialist offerings. In 2022, Healthcare at Home rebranded to Sciensus. This name change signaled a strategic shift to better reflect its evolution into a science-led, pan-European healthcare provider. Today, Sciensus operates across Europe, managing a wide range of services from medication supply and nursing to patient support programs, demonstrating the power of a focused, specialized approach to transforming healthcare delivery.
Tech stack
Investments by Sciensus
Edit